請用此 Handle URI 來引用此文件:
http://tdr.lib.ntu.edu.tw/jspui/handle/123456789/18224
完整後設資料紀錄
DC 欄位 | 值 | 語言 |
---|---|---|
dc.contributor.advisor | 詹東榮 | |
dc.contributor.author | Ping-Yen Wang | en |
dc.contributor.author | 王屏燕 | zh_TW |
dc.date.accessioned | 2021-06-08T00:55:31Z | - |
dc.date.copyright | 2015-03-16 | |
dc.date.issued | 2015 | |
dc.date.submitted | 2015-02-13 | |
dc.identifier.citation | Abdelhalim, M.A., 2011. Exposure to gold nanoparticles produces cardiac tissue damage that depends on the size and duration of exposure. Lipids Health Dis 10, 205-209.
Abdelhalim, M.A., Abdelmottaleb Moussa, S.A., 2013. The gold nanoparticle size and exposure duration effect on the liver and kidney function of rats: In vivo. Saudi J Biol Sci 20, 177-181. Abdelhalim, M.A., Jarrar, B.M., 2011. Renal tissue alterations were size-dependent with smaller ones induced more effects and related with time exposure of gold nanoparticles. Lipids Health Dis 10, 163-167. Almeida, J.P., Chen, A.L., Foster, A., Drezek, R., 2011. In vivo biodistribution of nanoparticles. Nanomedicine (London, England) 6, 815-835. Almeida, J.P., Figueroa, E.R., Drezek, R.A., 2014a. Gold nanoparticle mediated cancer immunotherapy. Nanomedicine 10, 503-514. Almeida, J.P., Lin, A.Y., Langsner, R.J., Eckels, P., Foster, A.E., Drezek, R.A., 2014b. In vivo immune cell distribution of gold nanoparticles in naive and tumor bearing mice. Small (Weinheim an der Bergstrasse, Germany) 10, 812-819. Bancos, S., Stevens, D.L., Tyner, K.M., 2015. Effect of silica and gold nanoparticles on macrophage proliferation, activation markers, cytokine production, and phagocytosis in vitro. International journal of nanomedicine 10, 183-206. Beck, L., Spiegelberg, H.L., 1989. The polyclonal and antigen-specific IgE and IgG subclass response of mice injected with ovalbumin in alum or complete Freund's adjuvant. Cell Immunol 123, 1-8. Black, C.A., 1999. Delayed type hypersensitivity: current theories with an historic perspective. Dermatol Online J 5, 7. Bunt, S.K., Yang, L., Sinha, P., Clements, V.K., Leips, J., Ostrand-Rosenberg, S., 2007. Reduced inflammation in the tumor microenvironment delays the accumulation of myeloid-derived suppressor cells and limits tumor progression. Cancer Res 67, 10019-10026. Charlton, B., Lafferty, K.J., 1995. The Th1/Th2 balance in autoimmunity. Curr Opin Immunol 7, 793-798. Chen, Y.P., Dai, Z.H., Liu, P.C., Chuu, J.J., Lee, K.Y., Lee, S.L., Chen, Y.J., 2012. Effects of nanogold on the alleviation of carbon tetrachloride-induced hepatic injury in rats. Chin J Physiol 55, 331-336. Chen, Y.S., Hung, Y.C., Lin, L.W., Liau, I., Hong, M.Y., Huang, G.S., 2010. Size-dependent impairment of cognition in mice caused by the injection of gold nanoparticles. Nanotechnology 21, 485102. Cher, D.J., Mosmann, T.R., 1987. Two types of murine helper T cell clone. II. Delayed-type hypersensitivity is mediated by TH1 clones. J Immunol 138, 3688-3694. Connor, E.E., Mwamuka, J., Gole, A., Murphy, C.J., Wyatt, M.D., 2005. Gold nanoparticles are taken up by human cells but do not cause acute cytotoxicity. Small 1, 325-327. Doncarli, A., Stasiuk, L.M., Fournier, C., Abehsira-Amar, O., 1997. Conversion in vivo from an early dominant Th0/Th1 response to a Th2 phenotype during the development of collagen-induced arthritis. Eur J Immunol 27, 1451-1458. Dykman, L.A., Sumaroka, M.V., Staroverov, S.A., Zaitseva, I.S., Bogatyrev, V.A., 2004. [Immunogenic properties of the colloidal gold]. Izv Akad Nauk Ser Biol, 86-91. Finkelman, F.D., Holmes, J., Katona, I.M., Urban, J.F., Jr., Beckmann, M.P., Park, L.S., Schooley, K.A., Coffman, R.L., Mosmann, T.R., Paul, W.E., 1990. Lymphokine control of in vivo immunoglobulin isotype selection. Annu Rev Immunol 8, 303-333. Fraga, S., Brandao, A., Soares, M.E., Morais, T., Duarte, J.A., Pereira, L., Soares, L., Neves, C., Pereira, E., Bastos Mde, L., Carmo, H., 2014. Short- and long-term distribution and toxicity of gold nanoparticles in the rat after a single-dose intravenous administration. Nanomedicine 10, 1757-1766. Fraga, S., Faria, H., Soares, M.E., Duarte, J.A., Soares, L., Pereira, E., Costa-Pereira, C., Teixeira, J.P., de Lourdes Bastos, M., Carmo, H., 2013. Influence of the surface coating on the cytotoxicity, genotoxicity and uptake of gold nanoparticles in human HepG2 cells. J Appl Toxicol 33, 1111-1119. Fytianos, K., Rodriguez-Lorenzo, L., Clift, M.J., Blank, F., Vanhecke, D., von Garnier, C., Petri-Fink, A., Rothen-Rutishauser, B., 2014. Uptake efficiency of surface modified gold nanoparticles does not correlate with functional changes and cytokine secretion in human dendritic cells in vitro. Nanomedicine NBM XX, 1-12. Gabrilovich, D.I., Nagaraj, S., 2009. Myeloid-derived suppressor cells as regulators of the immune system. Nat Rev Immunol 9, 162-174. Gliga, A.R., Skoglund, S., Wallinder, I.O., Fadeel, B., Karlsson, H.L., 2014. Size-dependent cytotoxicity of silver nanoparticles in human lung cells: the role of cellular uptake, agglomeration and Ag release. Part Fibre Toxicol 11, 11-18. Goodman, C.M., McCusker, C.D., Yilmaz, T., Rotello, V.M., 2004. Toxicity of gold nanoparticles functionalized with cationic and anionic side chains. Bioconjug Chem 15, 897-900. Gosens, I., Post, J.A., de la Fonteyne, L.J., Jansen, E.H., Geus, J.W., Cassee, F.R., de Jong, W.H., 2010. Impact of agglomeration state of nano- and submicron sized gold particles on pulmonary inflammation. Part Fibre Toxicol 7, 37. Gualtieri, M., Skuland, T., Iversen, T.G., Lag, M., Schwarze, P., Bilanicova, D., Pojana, G., Refsnes, M., 2012. Importance of agglomeration state and exposure conditions for uptake and pro-inflammatory responses to amorphous silica nanoparticles in bronchial epithelial cells. Nanotoxicology 6, 700-712. Heath, W.R., Carbone, F.R., 2001. Cross-presentation in viral immunity and self-tolerance. Nat Rev Immunol 1, 126-134. Hirn, S., Semmler-Behnke, M., Schleh, C., Wenk, A., Lipka, J., Schaffler, M., Takenaka, S., Moller, W., Schmid, G., Simon, U., Kreyling, W.G., 2011. Particle size-dependent and surface charge-dependent biodistribution of gold nanoparticles after intravenous administration. Eur J Pharm Biopharm 77, 407-416. Horisberger, M., Clerc, M.F., 1985. Labelling of colloidal gold with protein A. A quantitative study. Histochemistry 82, 219-223. Hussain, S., Vanoirbeek, J.A., Luyts, K., De Vooght, V., Verbeken, E., Thomassen, L.C., Martens, J.A., Dinsdale, D., Boland, S., Marano, F., Nemery, B., Hoet, P.H., 2011. Lung exposure to nanoparticles modulates an asthmatic response in a mouse model. Eur Respir J 37, 299-309. Hutter, E., Boridy, S., Labrecque, S., Lalancette-Hebert, M., Kriz, J., Winnik, F.M., Maysinger, D., 2010. Microglial response to gold nanoparticles. ACS nano 4, 2595-2606. Hwang, J.H., Kim, S.J., Kim, Y.H., Noh, J.R., Gang, G.T., Chung, B.H., Song, N.W., Lee, C.H., 2012. Susceptibility to gold nanoparticle-induced hepatotoxicity is enhanced in a mouse model of nonalcoholic steatohepatitis. Toxicology 294, 27-35. Ilovitsh, T., Danan, Y., Meir, R., Meiri, A., Zalevsky, Z., 2015. Cellular imaging using temporally flickering nanoparticles. Sci Rep 5, 8244. Jan, T.R., Su, S.T., Wu, H.Y., Liao, M.H., 2007. Suppressive effects of cannabidiol on antigen-specific antibody production and functional activity of splenocytes in ovalbumin-sensitized BALB/c mice. Int Immunopharmacol 7, 773-780. Jeong, E.H., Jung, G., Hong, C.A., Lee, H., 2014. Gold nanoparticle (AuNP)-based drug delivery and molecular imaging for biomedical applications. Arch Pharm Res 37, 53-59. Kang, M., Lim, C.H., Han, J.H., 2013. Comparison of toxicity and deposition of nano-sized carbon black aerosol prepared with or without dispersing sonication. Toxicological research 29, 121-127. Kariyone, A., Tamura, T., Kano, H., Iwakura, Y., Takeda, K., Akira, S., Takatsu, K., 2003. Immunogenicity of Peptide-25 of Ag85B in Th1 development: role of IFN-gamma. Int Immunol 15, 1183-1194. Lee, I.H., Kwon, H.K., An, S., Kim, D., Kim, S., Yu, M.K., Lee, J.H., Lee, T.S., Im, S.H., Jon, S., 2012. Imageable antigen-presenting gold nanoparticle vaccines for effective cancer immunotherapy in vivo. Angew Chem Int Ed Engl 51, 8800-8805. Liptrott, N.J., Kendall, E., Nieves, D.J., Farrell, J., Rannard, S., Fernig, D.G., Owen, A., 2014. Partial mitigation of gold nanoparticle interactions with human lymphocytes by surface functionalization with a 'mixed matrix'. Nanomedicine (Lond) 9, 2467-2479. Liu, Z., Li, W., Wang, F., Sun, C., Wang, L., Wang, J., Sun, F., 2012. Enhancement of lipopolysaccharide-induced nitric oxide and interleukin-6 production by PEGylated gold nanoparticles in RAW264.7 cells. Nanoscale 4, 7135-7142. Mackey, M.F., Barth, R.J., Jr., Noelle, R.J., 1998. The role of CD40/CD154 interactions in the priming, differentiation, and effector function of helper and cytotoxic T cells. J Leukoc Biol 63, 418-428. Mieszawska, A.J., Mulder, W.J., Fayad, Z.A., Cormode, D.P., 2013. Multifunctional gold nanoparticles for diagnosis and therapy of disease. Mol Pharm 10, 831-847. Morokata, T., Ishikawa, J., Yamada, T., 2000. Antigen dose defines T helper 1 and T helper 2 responses in the lungs of C57BL/6 and BALB/c mice independently of splenic responses. Immunol Lett 72, 119-126. Mosmann, T., 1983. Rapid colorimetric assay for cellular growth and survival: application to proliferation and cytotoxicity assays. J Immunol Methods 65, 55-63. Muller, K.H., Motskin, M., Philpott, A.J., Routh, A.F., Shanahan, C.M., Duer, M.J., Skepper, J.N., 2014. The effect of particle agglomeration on the formation of a surface-connected compartment induced by hydroxyapatite nanoparticles in human monocyte-derived macrophages. Biomaterials 35, 1074-1088. Niikura, K., Matsunaga, T., Suzuki, T., Kobayashi, S., Yamaguchi, H., Orba, Y., Kawaguchi, A., Hasegawa, H., Kajino, K., Ninomiya, T., Ijiro, K., Sawa, H., 2013. Gold nanoparticles as a vaccine platform: influence of size and shape on immunological responses in vitro and in vivo. ACS nano 7, 3926-3938. Noel, A., Charbonneau, M., Cloutier, Y., Tardif, R., Truchon, G., 2013. Rat pulmonary responses to inhaled nano-TiO(2): effect of primary particle size and agglomeration state. Part Fibre Toxicol 10, 48. Powell, M.C., Kanarek, M.S., 2006. Nanomaterial health effects--part 1: background and current knowledge. WMJ 105, 16-20. Schaeublin, N.M., Braydich-Stolle, L.K., Schrand, A.M., Miller, J.M., Hutchison, J., Schlager, J.J., Hussain, S.M., 2011. Surface charge of gold nanoparticles mediates mechanism of toxicity. Nanoscale 3, 410-420. Schatz, A.R., Koh, W.S., Kaminski, N.E., 1993. Delta 9-tetrahydrocannabinol selectively inhibits T-cell dependent humoral immune responses through direct inhibition of accessory T-cell function. Immunopharmacology 26, 129-137. Serafini, P., De Santo, C., Marigo, I., Cingarlini, S., Dolcetti, L., Gallina, G., Zanovello, P., Bronte, V., 2004. Derangement of immune responses by myeloid suppressor cells. Cancer Immunol Immunother 53, 64-72. Sharma, M., Salisbury, R.L., Maurer, E.I., Hussain, S.M., Sulentic, C.E., 2013. Gold nanoparticles induce transcriptional activity of NF-kappaB in a B-lymphocyte cell line. Nanoscale 5, 3747-3756. Shrivastava, R., Kushwaha, P., Bhutia, Y.C., Flora, S., 2014. Oxidative stress induced following exposure to silver and gold nanoparticles in mice. Toxicol Ind Health. Sinha, P., Clements, V.K., Bunt, S.K., Albelda, S.M., Ostrand-Rosenberg, S., 2007a. Cross-talk between myeloid-derived suppressor cells and macrophages subverts tumor immunity toward a type 2 response. J Immunol 179, 977-983. Sinha, P., Clements, V.K., Fulton, A.M., Ostrand-Rosenberg, S., 2007b. Prostaglandin E2 promotes tumor progression by inducing myeloid-derived suppressor cells. Cancer Res 67, 4507-4513. Sonavane, G., Tomoda, K., Makino, K., 2008. Biodistribution of colloidal gold nanoparticles after intravenous administration: effect of particle size. Colloids Surf B Biointerfaces 66, 274-280. Staroverov, S.A., Vidyasheva, I.V., Gabalov, K.P., Vasilenko, O.A., Laskavyi, V.N., Dykman, L.A., 2011. Immunostimulatory effect of gold nanoparticles conjugated with transmissible gastroenteritis virus. Bull Exp Biol Med 151, 436-439. Sultana, S., Djaker, N., Boca-Farcau, S., Salerno, M., Charnaux, N., Astilean, S., Hlawaty, H., de la Chapelle, M.L., 2015. Comparative toxicity evaluation of flower-shaped and spherical gold nanoparticles on human endothelial cells. Nanotechnology 26, 055101. Sumbayev, V.V., Yasinska, I.M., Garcia, C.P., Gilliland, D., Lall, G.S., Gibbs, B.F., Bonsall, D.R., Varani, L., Rossi, F., Calzolai, L., 2013. Gold nanoparticles downregulate interleukin-1beta-induced pro-inflammatory responses. Small 9, 472-477. Tomic, S., Ethokic, J., Vasilijic, S., Ogrinc, N., Rudolf, R., Pelicon, P., Vucevic, D., Milosavljevic, P., Jankovic, S., Anzel, I., Rajkovic, J., Rupnik, M.S., Friedrich, B., Colic, M., 2014. Size-dependent effects of gold nanoparticles uptake on maturation and antitumor functions of human dendritic cells in vitro. PLoS One 9, e96584. Tsai, C.Y., Lu, S.L., Hu, C.W., Yeh, C.S., Lee, G.B., Lei, H.Y., 2012. Size-dependent attenuation of TLR9 signaling by gold nanoparticles in macrophages. J Immunol 188, 68-76. Wang, Y.T., Lu, X.M., Zhu, F., Zhao, M., 2014. The preparation of gold nanoparticles and evaluation of their immunological function effects on rats. Biomed Mater Eng 24, 885-892. Yen, H.J., Hsu, S.H., Tsai, C.L., 2009. Cytotoxicity and immunological response of gold and silver nanoparticles of different sizes. Small 5, 1553-1561. Zhang, X.D., Wu, H.Y., Wu, D., Wang, Y.Y., Chang, J.H., Zhai, Z.B., Meng, A.M., Liu, P.X., Zhang, L.A., Fan, F.Y., 2010. Toxicologic effects of gold nanoparticles in vivo by different administration routes. International journal of nanomedicine 5, 771-781. | |
dc.identifier.uri | http://tdr.lib.ntu.edu.tw/jspui/handle/123456789/18224 | - |
dc.description.abstract | 金奈米粒子因具多項優越的物理特性,使其應用於生醫領域大受歡迎。近來研究指出,金奈米粒子作為腫瘤抗原載體及免疫佐劑,應用於腫瘤免疫治療極具潛力。然而,金奈米粒子對免疫系統之影響仍有待釐清。本研究利用卵白蛋白(ovalbumin; OVA)免疫小鼠之模式探討金奈米粒子對抗原專一性免疫反應之作用。商品化之奈米金粒子的粒徑為50奈米,其溶液需調整離子濃度以進行靜脈注射,此時會產生2種粒徑大小之團聚化金奈米粒子溶液,其粒徑分別為86奈米以及86奈米及309奈米混合之奈米金溶液。BALB/c小鼠於第1至10天每天以靜脈注射給予團聚化金奈米粒子(1 mg/kg),於第2天給予OVA免疫,於第9天進行血清中OVA特異性抗體及T細胞反應性之分析。第10天於小鼠足墊皮下注射OVA誘發遲發型過敏反應。並於24小時後量測足墊腫脹變化及組織病理檢查。實驗結果顯示靜脈投予金奈米粒子增加脾臟指數(spleen index)及脾臟中CD11b+ 細胞的比例。金奈米粒子對脾臟細胞代謝活性並無影響,但促進脾臟細胞表現OVA專一性之IFN-γ。金奈米粒子也促進脾臟細胞以脂多醣(lipopolysaccharide; LPS)刺激所分泌之IL-1β、IL-10和TNF-α表現量。血清中OVA專一性抗體及遲發型過敏反應則未受影響。本研究之結果指出金奈米粒子影響OVA免疫小鼠之部分免疫反應,包含增加脾臟指數和脾臟CD11b的細胞族群,以及促進脾臟細胞表現IFN-γ、IL-1β、IL-10和TNF-α。 | zh_TW |
dc.description.abstract | Gold nanoparticles (AuNPs) possess a number of unique physical properties that make them appealing for medical applications. Recently, AuNPs have been developed for cancer immunotherapy as immune adjuvants and vehicles for delivery of cancer antigens However, the influence of AuNPs on the immune system remains mostly unclear. The objective of the present study was to investigate the effect of AuNPs on antigen-specific immunity in ovalbumin (OVA)-sensitized mice. A commercial preparation of AuNPs whose particle size is 50 nm was employed in the present study. The AuNPs solution formed two sizes of agglomerates (86 nm AuNPs, and 86 nm and 309 nm mixed AuNPs) after electrolyte adjustment for intravenous (IV) administration. BALB/c mice were daily administered with the agglomerated AuNPs (1 mg/kg) by IV injection from day 1-10. The mice were intraperitoneally sensitized with ovalbumin (OVA) absorbed to alum on day 2. Serum levels of OVA-specific antibodies and T cell reactivity were examined on day 9. Delayed-type hypersensitivity (DTH) reaction was elicited by OVA challenge subcutaneously to the footpad of OVA-sensitized mice on day 10. Local inflammatory reactions were examined by measuring footpad swelling and histological analysis 24 h after the OVA challenge. Administration with AuNPs increased the spleen index and the population of CD11b+ cells in the spleen. The production of interferon (IFN)-γ by splenocytes re-stimulated with OVA in culture was markedly enhanced by AuNPs, whereas the metabolic activity of OVA-stimulated splenoyctes was unaffected. In addition, AuNPs enhanced the production of IL-1β, IL-10 and TNF-α by splenocytes stimulated with lipopolysaccharide (LPS). Serum levels of OVA-specific antibodies and DTH reaction were unaltered by AuNPs treatment. Collectively, the results demonstrated that systemic exposure to AuNPs affected some aspects of immunity in OVA-sensitized mice, including the increase of the spleen index and splenic CD11b+ population, and the enhancement of the production of IFN-γ, IL-1β, IL-10 and TNF-α by splenocytes. | en |
dc.description.provenance | Made available in DSpace on 2021-06-08T00:55:31Z (GMT). No. of bitstreams: 1 ntu-104-R01629019-1.pdf: 5423629 bytes, checksum: e10869a835be962b9458cce41f0738c7 (MD5) Previous issue date: 2015 | en |
dc.description.tableofcontents | 口試委員審定書 I
誌謝 II 中文摘要 III ABSTRACT IV CONTENTS VI LIST OF FIGURES VIII LIST OF TABLES IX ABBREVIATIONS X Chapter 1 Introduction 1 1.1 Background of nanoparticles 1 1.2 Gold nanoparticles 1 1.3 Toxicity of AuNPs 3 1.4 Immunological impacts of AuNPs 6 1.5 Agglomeration of nanoparticles 9 1.6 T cell-mediated immunity 12 1.7 Delayed-type hypersensitivity reactions 14 1.8 Objective of the study 15 Chapter 2 Materials and Methods 17 2.1 Chemicals and reagents 17 2.2 Animals 19 2.3 Animal study protocols 19 2.3.1 Protocol of AuNPs administration and OVA sensitization 19 2.3.2 Protocol of delayed-type hypersensitivity 22 2.4 Spleen Index determination 24 2.5 Splenocyte culture 24 2.6 Measurement of splenocyte metabolic activity 24 2.7 Measurement of cytokines by ELISA 25 2.8 Measurement of OVA-specific IgM, IgG1, and IgG2a by ELISA 28 2.9 Measurement of OVA-specific IgE by ELISA 28 2.10 Flow cytometric analysis of splenocyte cellularity 29 2.11 Histological analysis of footpads 30 2.12 Statistical analysis 30 Chapter 3 Results 31 3.1 Particle size analysis of AuNPs 31 3.2 Intravenous administration of AuNPs increased the spleen index and CD11b+ population of splenocytes in OVA-sensitized BALB/c mice 34 3.3 Differential effects of AuNPs on the production of antigen-specific cytokines by splenocytes 38 3.4 AuNPs treatment increased the production of IL-1β, IL-10 and TNF-α by splenocytes stimulated with LPS 42 3.5 AuNPs treatment did not affect the serum levels of OVA-specific antibodies 45 3.6 AuNPs treatment did not affect the DTH reaction in OVA-sensitized BALB/c mice 47 Chapter 4 Discussion 50 Chapter 5 Conclusion 56 References 57 | |
dc.language.iso | en | |
dc.title | 團聚化金奈米粒子對卵白蛋白免疫小鼠後天免疫反應的影響 | zh_TW |
dc.title | The Effect of Agglomerated Gold Nanoparticles on Adaptive Immune Responses in Ovalbumin-sensitized Mice | en |
dc.type | Thesis | |
dc.date.schoolyear | 103-1 | |
dc.description.degree | 碩士 | |
dc.contributor.oralexamcommittee | 梁弘人,詹銘煥,王家琪 | |
dc.subject.keyword | 金奈米粒子,免疫,小鼠,卵白蛋白,T細胞, | zh_TW |
dc.subject.keyword | gold nanoparticle,immune,mouse,ovalbumin,T cell, | en |
dc.relation.page | 62 | |
dc.rights.note | 未授權 | |
dc.date.accepted | 2015-02-13 | |
dc.contributor.author-college | 獸醫專業學院 | zh_TW |
dc.contributor.author-dept | 獸醫學研究所 | zh_TW |
顯示於系所單位: | 獸醫學系 |
文件中的檔案:
檔案 | 大小 | 格式 | |
---|---|---|---|
ntu-104-1.pdf 目前未授權公開取用 | 5.3 MB | Adobe PDF |
系統中的文件,除了特別指名其著作權條款之外,均受到著作權保護,並且保留所有的權利。